Walleye Trading
ALDR

Walleye Trading’s Alder Biopharmaceuticals ALDR Stock Holding History

Walleye Trading’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,700
Closed -$258K – 4864
2019
Q3 		$258K Buy
+13,700
New +$157K ﹤0.01% 2732

Walleye Trading's ALDR Position: Q4 2019 in Review

Walleye Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 119,720 shares — an estimated $2.26M sold.

Walleye Trading first reported a position in ALDR in Q2 2015 and held it in 3 quarters. The position peaked at $2.26M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Walleye Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Walleye Trading sold 119,720 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.26M.
  • Walleye Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Walleye Trading's Alder Biopharmaceuticals position peaked at $2.26M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Walleye Trading's 13F filing for Q4 2019, filed 14 Feb 2020.